Here, we showed RBFOX2 target exons are differentially spliced between normal pancreas and pancreatic cancer, suggesting that alternative splicing of these exons is an integral part of pancreatic cancer progression. The gene discussed is RBFOX2; the disease is familial pancreatic carcinoma.